🔴 HCW Biologics is trading 5.8% down today on higher oil prices and Treasury yields

HCW Biologics is trading 5.8% down at $1.71, with broader market pressure the likeliest explanation.

• No fresh company-specific catalyst was identified; the Akron Biotech distribution agreement and T-cell engager milestones predate the decline.
• The decline followed opening-session weakness on September 23, 2026, as higher oil prices, Treasury yields and weaker risk appetite pressured the broader market.
• HCW Biologics is diverging from the biotech sector’s advance.